Novo Nordisk's Ozempic successor disappointed Wall Street again
Novo Nordisk (NVO) released clinical trial results for its potential Ozempic successor on Monday, disappointing Wall Street for the second time.Read more...
We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.
Wegovy's price cut, Amgen's Ozempic competitor, and Big Pharma's tax cut: P
<img class="type:primaryImage" src="https://i.kinja-img.com/image/upload/c_fit,q_80,w_636/e52d965976c1e0c2f8d89ccb548a2577.jpg"/><p>Novo Nordisk just cut the price of i [...]
Coinbase says Trump’s SEC has ended its enforcement case against the cryp
<p>Coinbase says that the SEC <a data-i13n="cpos:1;pos:1" href="https://investor.coinbase.com/financials/sec-filings/sec-filings-details/default.aspx?FilingId=18209257"> [...]
Major publishers sue AI startup Cohere over copyright infringement
<p>Major publishers, including <em>Politico</em> and <em>Vox</em>, and their parent companies are suing the AI startup Cohere for copyright and trademark infringement, &l [...]
<p>Elon Musk launched a $97.4 billion bid to take control of OpenAI. <a data-i13n="elm:affiliate_link;sellerN:The Wall Street Journal;elmt:;cpos:1;pos:1" href="https://shopping [...]
<p>Elon Musk has launched a $97.4 billion bid to take control of OpenAI. <a data-i13n="elm:affiliate_link;sellerN:The Wall Street Journal;elmt:;cpos:1;pos:1" href="https://shop [...]